Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences
MJH Life Sciences

SUBSCRIBE: Print / eNewsletter

ASH Lymphoma 2019

ASH Lymphoma

Lenalidomide/Rituximab Combo Improves PFS in Subgroup of Patients with NHL

December 9, 2019
  • Gina Columbus

Treatment with lenalidomide and rituximab improved progression-free survival, compared with placebo in patients ≥70 years old with indolent non-Hodgkin lymphoma.

  • READ >>

Liso-Cel Shows Promise in Relapsed/Refractory Large B-Cell Lymphoma

December 9, 2019
  • Wayne Kuznar

Lisocabtagene maraleucel induced high response rates in patients with aggressive relapsed/refractory large B-cell lymphoma.

  • READ >>

Combination Therapy Induces High Response Among Relapsed/Refractory Follicular Lymphoma

December 8, 2019
  • Kristie L. Kahl

The combination use of polatuzumab-vedotin, obinutuzumab, and lenalidomide showed high complete response rates in patients with relapsed/refractory follicular lymphoma.

  • READ >>

Axi-Cel Improves OS in Patients with Refractory B-Cell Lymphoma

December 7, 2019
  • Silas Inman

The CAR T-cell therapy axicabtagene ciloleucel induced a median overall survival of 25.8 months for patients with refractory large B-cell lymphoma.

  • READ >>

Off-The-Shelf Immunotherapy Product Induces Positive Response in Patients with NHL

December 7, 2019
  • Anita Shaffer

Mosunetuzumab generated durable responses in patients with highly refractory non-Hodgkin lymphomas.

  • READ >>

Tanya Siddiqi, MD, Discusses the TRANSCEND CLL-004 Trial

December 6, 2019
  • Hannah Slater

Tanya Siddiqi, MD, discussed the CAR T-cell trial ahead of the ASH Annual Meeting & Exposition in an interview with CancerNetwork®.

  • READ >>

CAR T-Cell Therapy Studies to Look for at the ASH Annual Meeting

November 27, 2019
  • Kristie L. Kahl

Research on chimeric antigen receptor T-cell therapy to be presented at the ASH Annual Meeting & Exposition is set to address drawbacks associated with treatment.

  • READ >>

Promising New Prognostic Score for High-Risk DLBCL

December 18, 2018
  • Naveed Saleh, MD, MS

Researchers compared the ability of a novel prognostic score vs existing scores to identify patients with high-risk DLBCL.

  • READ >>

The Long-Term Outlook for Mogamulizumab in Previously Treated Cutaneous T-Cell Lymphoma

December 6, 2018
  • Traci DeVito

The results of a follow-up analysis to the phase III MAVORIC study were presented at the ASH 2018 Annual Meeting & Exposition.

  • READ >>

Impact of Checkpoint Blockade Therapy on Subsequent Treatment in Non-Hodgkin Lymphoma Patients

December 5, 2018
  • Naveed Saleh, MD, MS

Research presented at ASH 2018 examined whether checkpoint blockade therapy sensitizes patients with relapsed/refractory NHL to consequent treatment.

  • READ >>

Pages

  • 1
  • 2
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Breast Cancer
  • Acute Myeloid Leukemia
  • HER2-Positive Breast Cancer
  • Videos Breast Cancer
  • Follicular Lymphoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

ONCOLOGY Vol 33 No 11
Nov 21, 2019 Vol 33 No 11
Subscribe
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".